Lipid Nutrition’s gets FDA GRAS for PinnoThin
The Food and Drug Administration has issued a letter of no objection for Lipid Nutrition’s PinnoThin ingredient, thereby confirming the Generally Recognised As Safe (GRAS) status of the ingredient.
News, Analysis & Insights on Nutrition, Supplements, and Health
The Food and Drug Administration has issued a letter of no objection for Lipid Nutrition’s PinnoThin ingredient, thereby confirming the Generally Recognised As Safe (GRAS) status of the ingredient.
The Food and Drug Administration has revised three selenium, qualified health claims, after a court reiterated earlier rulings and ordered it to do so in July.
Combining statins with omega-3 fatty acids may be more effective at managing raised blood lipid levels than statins alone, suggests a new study from Korea.
A detailed description of the fatty acid profile of krill oil has revealed a high content of phospholipid omega-3 fatty acid, and may aid future product development.
Vitamin D supplements do not have any effect in boosting bone density for healthy children with normal vitamin D status, according to a new systematic review from the Cochrane collaboration.